ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2206

Detection Of State-Specific RNA Transcripts In Juvenile Idiopathic Arthritis Neutrophils Using RNA Sequencing

Kaiyu Jiang1, Xiaoyun Sun2, Yanmin Chen1, Yufeng Shen2 and James N. Jarvis1, 1Pediatrics, The University at Buffalo, Buffalo, NY, 2Center for Computational Biology & Bioinformatics, Columbia University, New York, NY

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Gene Expression, Genomics and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Once considered non-functional, the vast regions of the human genome that do not contain protein-coding genes are now known to contain important regulatory elements.  These regulatory elements include both enhancer regions and regions encoding regulatory RNA transcripts such as long non-coding RNA (lncRNA).  These studies were undertaken to examine in detail the transcriptome of  neutrophils in children with polyarticular juvenile idiopathic arthritis (JIA). 

Methods: We isolated RNA from neutrophils of children with 3 different phenotypes: children with active, untreated disease (AD, n=3), children on medication who fit criteria for remission by the Wallace criteria (CRM, n=3), and children with cystic fibrosis (CF, n=3), a control group designed to distinguish those transcriptome features specific to JIA and those common to other forms of chronic, soft tissue inflammation.  RNA samples were prepared for sequencing using the Illumina TruSeq RNA prep kit. Sequencing was performed using the Illumina HiSeq 2000. The pass filter reads were mapped to the genome (NCBI/build 37.2 ) using TopHat (version 2.0.4). Probable transcripts were assembled using Cufflinks (version 2.0.2), and differential expressed transcripts were determined using DESeq. Fold change (FC) calculations were obtained using the log2(FPKM) ratio, where FPKM is the fragments per kilobase of exon model per million mapped fragments.

Results: For all phenotypes, we detected between 8,000-9,000 expressed genes, with children in CRM showing the highest number of expressed genes (n=8,668).  Of these, 7,734 were common to all 3 phenotypes.  Multiple isoforms of known genes were expressed in the 3 phenotypes, most of which were common to all 3. Of the protein-coding regions, there are 62 differentially expressed genes (29 down-regulated, 33 up-regulated) in fold change 1.2 or greater when AD compared to CRM, 64 DE genes (6 down-regulated, 58 up-regulated) in the AD vs CF comparison and 90 DE (40 down-regulated, 50 up-regulated,) in CRM vs CF. Principle component analysis (PCA) and hierarchical cluster analysis of DE genes showed clear separation between AD, CRM and CF. The functional enrichment analysis using DAVID for the DE genes shows they are associated with immune response (IFIH1, C4A, IFITM3, TNFSF15, APOBEC3G, OAS1, C4BPA, TRIM22, NOD2, FCGR2C, P2RY14, HLA-DRB5, ODZ1, CFD), innate immune response (IFIH1, NOD2, C4A, APOBEC3G, C4BPA, CFD), and inflammatory response (ORM1, TNFAIP6, C4A, IDO1, C4BPA, CFD, SPP1), etc. Finally, novel, previously uncharacterized transcripts were seen in each of the 3 phenotypes (n=5 for AD, n=11 for CRM, and n=9 for CF).  These transcripts may represent previously-unknown lncRNA transcripts.

Conclusion: The sensitivity and dynamic range of RNAseq allow a much more detailed view of the neutrophil transcriptome.  The finding of state-specific transcripts is expected to lead to new insights into JIA pathogenesis, response to therapy, and the development of diagnostic and prognostic biomarkers.


Disclosure:

K. Jiang,
None;

X. Sun,
None;

Y. Chen,
None;

Y. Shen,
None;

J. N. Jarvis,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/detection-of-state-specific-rna-transcripts-in-juvenile-idiopathic-arthritis-neutrophils-using-rna-sequencing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology